NCT03832764

Brief Summary

During the current pain monitoring system the patient is awake and he/she is asked to give a numerical scale rating from 0 (no pain) to 10 (extreme pain). The purpose is to correlate the non-invasive measurements of the prototype device ANSPEC-PRO with these numbers to develop later a method/algorithm for automatic evaluation of pain (objective measurement of pain). The measurement is done using standard ECG electrodes placed in the hand palm of the patient. The patient feels nothing during the observations, perhaps irritation of skin may occur as result of long time measurement. As a comparison to the investigators prototype, a commercial device is also used in (randomly selected) patients, i.e. the MedStorm device. The study will try to answer the following questions:

  • Are the measurements with the ANSPEC-PRO correlated with the NRS values?
  • What is the (mathematical) relationship between the measured values and the NRS?
  • Is there difference between the two devices in measuring pain levels? And what is this difference if pain alleviation medication is given to the patient?
  • A number of 26 patients is envisaged for this study, equally distributed to be evaluated with the two devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
Last Updated

February 6, 2019

Status Verified

February 1, 2019

Enrollment Period

2 months

First QC Date

September 11, 2018

Last Update Submit

February 5, 2019

Conditions

Keywords

skin impedancepain monitoringobservational studyPACU/ICU

Outcome Measures

Primary Outcomes (1)

  • Evaluation of a new non-invasive painmonitor used in clinic awakening, postoperative patients.

    Pain monitoring of awake patients which are standardly treated for pain using the numerical rating scale. The main outcome is a correlation between ANSPEC-PRO device and the numerical rating scale.

    140 minutes each patient

Study Arms (2)

ANSPEC-PRO

These patients are selected (after randomized selection) to be monitored non-invasively for pain level via prototype ANSPEC-PRO - correlated to a NRS number given by the awake patient in PACU/ICU.

Device: ANSPEC-PRO

MEDSTORM

These patients are selected (after randomized selection) to be monitored non-invasively for pain level via MEDSTORM - correlated to a NRS number given by the awake patient in PACU/ICU.

Device: ANSPEC-PRO

Interventions

Device monitors for 140 minutes continuously the pain levels in awake patients in PACU/ICU

Also known as: MEDSTORM
ANSPEC-PROMEDSTORM

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients planned for operation, between 18 and 70 years old, not pregnant, not in chronic pain and not taken anticonvulsants or antidepressants.

You may qualify if:

  • patients postoperative of a painfull operation
  • between 18 and70 years old

You may not qualify if:

  • day surgery patients
  • chronic pain patients
  • taken medication : anticonvulsants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clara Ionescu

Ghent, Oost-Vlaanderen, 9000, Belgium

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2018

First Posted

February 6, 2019

Study Start

May 1, 2018

Primary Completion

June 26, 2018

Study Completion

June 26, 2018

Last Updated

February 6, 2019

Record last verified: 2019-02

Locations